Compare LLY & MA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLY | MA |
|---|---|---|
| Founded | 1876 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 979.6B | 431.9B |
| IPO Year | 2007 | 2005 |
| Metric | LLY | MA |
|---|---|---|
| Price | $1,111.65 | $494.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 26 |
| Target Price | ★ $1,218.84 | $649.19 |
| AVG Volume (30 Days) | 2.4M | ★ 3.6M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.81% | 0.66% |
| EPS Growth | ★ 95.99 | 18.93 |
| EPS | ★ 8.26 | 4.35 |
| Revenue | ★ $65,179,000,000.00 | $32,791,000,000.00 |
| Revenue This Year | $27.15 | $16.19 |
| Revenue Next Year | $16.04 | $12.35 |
| P/E Ratio | $134.12 | ★ $112.21 |
| Revenue Growth | ★ 44.70 | 16.42 |
| 52 Week Low | $623.78 | $464.52 |
| 52 Week High | $1,182.73 | $601.77 |
| Indicator | LLY | MA |
|---|---|---|
| Relative Strength Index (RSI) | 56.86 | 51.98 |
| Support Level | $1,032.70 | $487.11 |
| Resistance Level | $1,165.92 | $529.49 |
| Average True Range (ATR) | 33.94 | 9.83 |
| MACD | -8.43 | 0.79 |
| Stochastic Oscillator | 31.60 | 65.40 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Mastercard is the second-largest payment processor in the world, having processed close to $11 trillion in volume during 2025. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.